Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
By Li Wei, T. MacDonald, B. Walker. Annals of Internal Medicine, 2004
758 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/f35921203752fc72591765c684f351434ae9485a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- K. Chapman
- B. Biller
- J. Findling
- P. Stewart
- J. Newell-Price
- Halea Meese
- M. Savage
- M. Holmes
Citations in the corpus
- 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. (2013, background): “Nonetheless, glucocorticoids remain among the most prescribed medicines (758).”
- A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy (2013, unknown): “5 mg of prednisone daily [53].”
- The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis (2015, unknown): “In”
- Long-term side effects of glucocorticoids (2016, background): “5 mg or more of prednisolone.[33] This is an indirect side effect of hypertension, hyperglycemia and hypertriglyceride-”
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. (2007, unknown): “[184].”
- The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. (2008, result): “These data are consistent with the increased cardiovascular mortality and morbidity reported in patients with iatrogenic Cushing’s syndrome secondary to the chronic use of synthetic corticosteroids (15).”